Until now, we have identified some expected difficulties including systematic errors (errors in the selection methods of eligible patients), errors in the instruments (TILs determined from the tumor tissue), incomplete data from the observation sheets, and no other data of potential biomarkers (PD-L1 testing and HPV testing). Here, CD274 is linked to neoplasm.